“Locked onto the target”: increasing the efficiency of antagomirzymes using locked nucleic acid modifications.

This study highlights the effect of incorporation of locked nucleic acid (LNA) on improving the functional efficacy of DNAzymes against microRNAs (antagomirzymes). DNAzymes were designed against two different sites of miR-27a, which were encompassed both within the precursor and mature form of miRNA. The cleavage and functional activities of these DNAzymes have been compared to those of LNA-modified counterparts, containing LNA modification in each of the substrate binding arms. Preliminary examination based on in vitro cleavage demonstrated LNAzyme to be much more effective in the ensuing cleavage of target miRNA under both single- and multiple-turnover conditions. Evaluation of kinetic parameters indicated almost 5-fold higher cleavage efficiency, kobs, for LNAzymes than for DNAzymes, leading to more efficient cleavage of the substrate. We attribute this enhancement in cleavage efficiency to the LNA-mediated improvement in the hybridization of the antagomirzyme·target complex. Functional validation of the relative activities was accomplished through the luciferase reporter assay and quantitative real-time polymerase chain reaction (qRT-PCR). Both the unmodified and LNA-modified antagomirzymes were very active in ensuing efficient miRNA knockdown; however, compared to the DNAzymes, the LNAzymes were almost 25% more active. A direct quantitative estimate of miRNA cleavage, conducted using qRT-PCR, further substantiated the data by indicating that LNAzyme effectively downregulated the levels of mature miRNA (up to 50%) versus the corresponding DNAzymes. Our data thus provide formative evidence of the successful employment of LNA-based antagomirzymes against miRNA.

[1]  Yingfu Li,et al.  Probing the function of nucleotides in the catalytic cores of the 8-17 and 10-23 DNAzymes by abasic nucleotide and C3 spacer substitutions. , 2010, Biochemistry.

[2]  J. Montserrat,et al.  10-23 DNAzyme modified with (2'R)- and (2'S)-2'-deoxy-2'-C-methyluridine in the catalytic core. , 2010, Bioorganic & medicinal chemistry letters.

[3]  E. Berns,et al.  MicroRNAs in ovarian cancer biology and therapy resistance. , 2010, The international journal of biochemistry & cell biology.

[4]  P. Bugert,et al.  A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk , 2010, Breast Cancer Research and Treatment.

[5]  V. Scaria,et al.  Upregulation of miR-23a∼27a∼24-2 Cluster Induces Caspase-Dependent and -Independent Apoptosis in Human Embryonic Kidney Cells , 2009, PloS one.

[6]  V. Scaria,et al.  Antagomirzymes: oligonucleotide enzymes that specifically silence microRNA function. , 2009, Angewandte Chemie.

[7]  Min Liu,et al.  MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. , 2009, Cancer letters.

[8]  Yanjie Lu,et al.  A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference , 2009, Nucleic acids research.

[9]  Danish Sayed,et al.  MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. , 2008, Molecular biology of the cell.

[10]  J. Stenvang,et al.  The utility of LNA in microRNA-based cancer diagnostics and therapeutics. , 2008, Seminars in cancer biology.

[11]  S. Maiti,et al.  Thermodynamics of DNA-RNA heteroduplex formation: effects of locked nucleic acid nucleotides incorporated into the DNA strand. , 2008, Biochemistry.

[12]  S. Maiti,et al.  Perspectives on chemistry and therapeutic applications of Locked Nucleic Acid (LNA). , 2007, Chemical reviews.

[13]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[14]  V. Scaria,et al.  microRNA: an Emerging Therapeutic , 2007, ChemMedChem.

[15]  B. Berkhout,et al.  Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites , 2007, Retrovirology.

[16]  S. Maiti,et al.  LNA-modified oligonucleotides effectively drive intramolecular-stable hairpin to intermolecular-duplex state. , 2007, Biochemical and biophysical research communications.

[17]  S. Maiti,et al.  Thermodynamic, counterion, and hydration effects for the incorporation of locked nucleic acid nucleotides into DNA duplexes. , 2006, Biochemistry.

[18]  L. H. Hansen,et al.  Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets , 2006, BMC Molecular Biology.

[19]  R. Shiekhattar,et al.  MicroRNA biogenesis and cancer. , 2005, Cancer research.

[20]  V. Erdmann,et al.  Deletion analysis in the catalytic region of the 10–23 DNA enzyme , 2005, FEBS letters.

[21]  S. Schubert,et al.  Ribozyme- and deoxyribozyme-strategies for medical applications. , 2004, Current drug targets.

[22]  V. Erdmann,et al.  Gaining target access for deoxyribozymes. , 2004, Journal of molecular biology.

[23]  S. Douthwaite,et al.  Improved RNA cleavage by LNAzyme derivatives of DNAzymes. , 2004, Biochemical Society transactions.

[24]  V. Erdmann,et al.  RNA cleaving '10-23' DNAzymes with enhanced stability and activity. , 2003, Nucleic acids research.

[25]  V. Erdmann,et al.  Sequence Requirements in the Catalytic Core of the “10-23” DNA Enzyme* , 2002, The Journal of Biological Chemistry.

[26]  S. Douthwaite,et al.  LNAzymes: incorporation of LNA-type monomers into DNAzymes markedly increases RNA cleavage. , 2002, Journal of the American Chemical Society.

[27]  M. Cairns,et al.  Catalytic DNA: a novel tool for gene suppression. , 2002, Current drug targets.

[28]  V. Erdmann,et al.  Comparative Study of DNA Enzymes and Ribozymes against the Same Full-length Messenger RNA of the Vanilloid Receptor Subtype I* , 2002, The Journal of Biological Chemistry.

[29]  T. Hökfelt,et al.  Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Cairns,et al.  Nucleic acid mutation analysis using catalytic DNA. , 2000, Nucleic acids research.

[31]  Y. Hari,et al.  Stability and Structural Features of the Duplexes Containing Nucleoside Analogues with a Fixed N‐Type Conformation, 2′‐O,4′‐C‐Methyleneribonucleosides. , 1998 .

[32]  Y. Hari,et al.  Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2'-O,4'- C-methyleneribonucleosides , 1998 .

[33]  Poul Nielsen,et al.  LNA (Locked Nucleic Acids): Synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition , 1998 .

[34]  K. Breslauer,et al.  Salt‐dependent conformational transitions in the self‐complementary deoxydodecanucleotide d(CGCAATTCGCG): Evidence for hairpin formation , 1983, Biopolymers.

[35]  Poul Nielsen,et al.  LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition , 1998 .